Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Day 1 to Week 48	STARTED	ETV 0.5 mg	182
Day 1 to Week 48	STARTED	ETV 0.5 mg +TDF 300 mg	197
Day 1 to Week 48	COMPLETED	ETV 0.5 mg	176
Day 1 to Week 48	COMPLETED	ETV 0.5 mg +TDF 300 mg	185
Day 1 to Week 48	NOT COMPLETED	ETV 0.5 mg	6
Day 1 to Week 48	NOT COMPLETED	ETV 0.5 mg +TDF 300 mg	12
After Week 48 to Week 96	STARTED	ETV 0.5 mg	176
After Week 48 to Week 96	STARTED	ETV 0.5 mg +TDF 300 mg	185
After Week 48 to Week 96	COMPLETED	ETV 0.5 mg	170
After Week 48 to Week 96	COMPLETED	ETV 0.5 mg +TDF 300 mg	174
After Week 48 to Week 96	NOT COMPLETED	ETV 0.5 mg	6
After Week 48 to Week 96	NOT COMPLETED	ETV 0.5 mg +TDF 300 mg	11

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00410072/flow